Evaluating early-stage prostate cancer: What pretreatment criteria best guide therapeutic decision making?

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 565-579

  Corless, C L ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER CYTODIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; HUMAN; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; REVIEW; TREATMENT PLANNING;

EID: 0029894275     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70353-1     Document Type: Article

References (112)

1. D.A. Ackerman J.M. Barry R.A. Wicklund Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy J Urol 150 1993 1845
2. J. Adolfsson L. Ronstrom P.O. Hedlund The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer J Urol 144 1990 1404
3. M. Aihara R.M. Lebovitz T.M. Wheeler Prostate specific antigen and Gleason grade: An immunohistochemical study of prostate cancer J Urol 151 1994 1558
4. A.G. Aprikian A.S. Sarkis W.R. Fair Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma J Urol 151 1994 1276
5. G.O. Bain M. Koch J. Hanson Feasibility of grading prostatic carcinomas Arch Pathol Lab Med 106 1982 265
6. S.I. Bastacky P.C. Walsh J.I. Epstein Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate Am J Surg Pathol 17 1993 336
7. A. Berner H.E. Danielson E.O. Pettersen DNA distribution in the prostate Anal Quant Cytol Histol 15 1993 247
8. M.L. Blute O. Nativ H. Zincke Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy J Urol 142 1989 1262
9. M.L. Blute H. Zincke G.M. Farrow Long-term followup of young patients with stage A adenocarcinoma of the prostate J Urol 136 1986 840
10. R. Bookstein Tumor suppressor genes in prostatic oncogenesis J Cell Biochem 19 suppl 1994 217
11. D.G. Bostwick Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies Am J Surg Pathol 18 1994 796
12. D.P. Byar F.K. Mostofi Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies Cancer 30 1972 5
13. B.B. Cantrell D.P. DeKlerk J.C. Eggleston Pathologic factors that influence prognosis in stage A prostatic cancer: The influence of extent versus grade J Urol 125 1981 516
14. W.J. Catalona D.S. Smith T.L. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 948
15. W.J. Catalona A.J. Stein W.R. Fair Grading errors in prostatic needle biopsies: Relation to the accuracy of tumor grade in predicting pelvic lymph node metastases J Urol 127 1982 919
16. D.S. Coffey Prostate cancer. An overview of an increasing dilemma Cancer 71 suppl 1993 880
17. M.R. Cupp D.G. Bostwick R.P. Myers The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis J Urol 153 1995 1543
18. A.V. D'Amico R. Whittington S.B. Malkowicz A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer J Urol 154 1995 131
19. S.W. Dejter R.E. Cunningham P.D. Noguchi Prognostic significance of DNA ploidy in carcinoma of the prostate Urology 33 1989 361
20. D.D. Dietrick J.E. McNeal T.A. Stamey Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume Urology 45 1995 987
21. W.N. Dinjens M.M. van der Weiden F.H. Schroeder Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer Int J Cancer 56 1994 630
22. P.J. Effert R.H. McCoy P.J. Walther p53 gene alterations in human prostate carcinoma J Urol 150 1993 257
23. J.I. Epstein Cancer detected incidental to simple prostatectomy (stage A1) J Cell Biochem 16H suppl 1992 78
24. J.I. Epstein M. Carmichael A.W. Partin Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup J Urol 149 1993 1478
25. J.I. Epstein M. Carmichael P.C. Walsh Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade and margins of resection to prognosis J Urol 149 1993 1040
26. J.I. Epstein M.J. Carmichael A.W. Partin Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: Pathogenetic and clinical implications J Urol 151 1994 1587
27. J.I. Epstein M.J. Carmichael G. Pizov Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup J Urol 150 1993 135
28. J.I. Epstein J.E. Oesterling P.C. Walsh The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer J Urol 139 1988 975
29. J.I. Epstein G. Paull J.C. Eggleston Prognosis of untreated stage A1 prostatic carcinoma: A study of 94 cases with extended followup J Urol 136 1986 837
30. J.I. Epstein G. Pizov G.D. Steinberg Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape, and Gleason grade with pathologic stage at radical prostatectomy J Urol 148 1992 87
31. J.I. Epstein G. Pizov P.C. Walsh Correlation of pathologic findings with progression after radical retropubic prostatectomy Cancer 71 1993 3582
32. J.I. Epstein G.D. Steinberg The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume, and stage of the biopsied and multifocal tumor Cancer 66 1990 1927
33. J.I. Epstein P.C. Walsh M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
34. M.V.P. Forham A.H. Burdge J. Matthews Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome Br J Surg 73 1986 400
35. G. Forsslund E. Pier-Luigi B. Nilsson The prognostic significance of nuclear DNA content in prostatic carcinoma Cancer 69 1992 1432
36. J.E. Fowler S.E. Mills Operable prostatic carcinoma: Correlations among clinical stage, pathological stage, Gleason histologic score and early disease-free survival J Urol 134 1985 49
37. H.A. Frazier J.E. Robertson P.A. Humphrey Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy J Urol 149 1993 516
38. D.F. Gleason Histologic grading of prostate cancer: A perspective Hum Pathol 23 1992 273
39. D.F. Gleason G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical stage J Urol 111 1974 58
40. Y. Goto M. Ohori A. Arakawa Distinguishing clinically important from unimportant prostate cancers before treatment: Preliminary report J Urol 151 suppl 1994 289A
41. M.C. Hall N.M. Navone P. Troncoso Frequency and characterization of p53 mutations in clinically localized prostate cancer Urology 45 1995 470 475
42. P.W. Hinds R.A. Weinberg Tumor suppressor genes Curr Opin Genet Dev 4 1994 135
43. K.K. Hodge J.E. McNeal M.K. Terris Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71
44. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J Urol 142 1989 1011
45. P.A. Humphrey J. Baty D. Keetch Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues Cancer 75 1995 1842
46. P.A. Humphrey H.A. Frazier R.T. Vollmer Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels Cancer 71 1993 1821
47. P.A. Humphrey P.J. Walther S.M. Currin Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma Am J Surg Pathol 15 1991 1165
48. M.B. Irwin J.G. Trapasso Identification of insignificant prostate cancers: Analysis of preoperative parameters Urology 44 1994 862
49. M. Ittman R. Wieczorek P. Heller Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas Am J Pathol 145 1994 287
50. H.J. Jewett The results of radical perineal prostatectomy JAMA 210 1969 324
51. E. Kleer J.J. Larson-Keller H. Zincke Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy Urology 41 1993 207
52. S.A. Kramer J. Spahr C.B. Brendler Experience with Gleason's histopathologic grading in prostatic cancer J Urol 124 1980 223
53. M.P. Larsen H.B. Carter J.I. Epstein Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease J Urol 146 1991 1059
54. T. Loch J.E. McNeal T.A. Stamey Interpretation of bilateral positive biopsies in prostate cancer J Urol 154 1995 1078
55. B.A. Lowe M.B. Listrom Incidental carcinoma of the prostate: An analysis of the predictors of progression J Urol 140 1988 1340
56. A. Lundberg J. Carstensen I. Rundquist DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study Cancer Res 47 1987 1973
57. J.E. McNeal Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread Hum Pathol 23 1992 258
58. J.E. McNeal E.A. Redwine F.S. Freiha Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am J Surg Pathol 12 1988 897
59. J.E. McNeal A.A. Villers E.A. Redwine Capsular penetration in prostate cancer. Significance for natural history and treatment Am J Surg Pathol 14 1990 240
60. J.E. McNeal A.A. Villers E.A. Redwine Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate Cancer 66 1990 1225
61. C.J. Mettlin G. Murphy The national cancer data base report on prostate cancer Cancer 74 1994 1640
62. R.G. Middleton J.A. Smith Jr R.B. Melzer Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma J Urol 136 1986 422
63. S.E. Mills J.E. Fowler Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens Cancer 57 1986 346
64. J.M. Monda M.J. Barry J.E. Oesterling Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia J Urol 151 1994 1291
65. B.T. Montgomery O. Nativ M.L. Blute Stage B prostate adenocarcinoma flow cytometric nuclear DNA ploidy analysis Arch Surg 125 1990 327
66. J.E. Montie D.P. Wood Jr J.E. Pontes Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer Cancer 63 1989 381
67. G.P. Murphy W.F. Whitmore A report of the workshop on the current status of the histologic grading of prostatic cancer Cancer 44 1979 1490
68. R.B. Myers D. Oelschlager S. Srivastava Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas Prostate 25 1994 243
69. J.E. Oesterling Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 145 1991 907
70. M. Ohori J.R. Goad T.M. Wheeler Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152 1994 1843
71. J.P. Palazzo D. Ellison R.O. Petersen DNA content in prostate adenocarcinoma J Urol Pathol 1 1993 283
72. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
73. A.W. Partin J.I. Epstein K.R. Cho Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer J Urol 141 1989 341
74. A.W. Partin B.R. Lee M. Carmichael Radical prostatectomy for high grade disease: A reevaluation 1994 J Urol 151 1994 1583
75. A.W. Partin J.E. Oesterling The clinical usefulness of prostate specific antigen: Update 1994 J Urol 152 1994 1358
76. A.W. Partin C.R. Pound J.Q. Clemens Serum PSA after anatomic radical prostatectomy Urol Clin North Am 20 1993 713
77. A.W. Partin J. Yoo H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110
78. A.W. Partin J. Yoo H.B. Carter Letter to the Editor J Urol 152 1994 172
79. P.A. Peller D.C. Young D.P. Marmaduke Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens Cancer 75 1995 530
80. J.M. Peters B.J. Miles J.J. Kubus Prognostic significance of the nuclear DNA content in localized prostatic adenocarcinoma Anal Quant Cytol Histol 12 1990 359
81. R.O. Petersen Urologic Pathology ed 2 1992 JB Lippincott Philadelphia 594
82. J.M. Peters-Gee B.J. Miles J.C. Cerny Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis Cancer 70 1992 1159
83. G. Pezzino P.L. Remington H.A. Anderson Trends in the surgical treatment of prostate cancer in Wisconsin, 1989-1991 J Natl Cancer Inst 86 1994 1083
84. A.W.S. Ritchie F. Dorey L.J. Layfield Relationship of DNA content to conventional prognostic factors in clinically localized carcinoma of the prostate Br J Urol 62 1988 254
85. H.C. Ruckle G.G. Klee J.E. Oesterling Prostate-specific antigen: Critical issues for the practicing physician Mayo Clin Proc 69 1994 59
86. W.A. Sakr G.P. Haas B.F. Cassin The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients J Urol 150 1993 379
87. R. Scaletscky M.O. Koch C.W. Eckstein Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 152 1994 129
88. P.T. Scardino R. Weaver M.A. Hudson Early detection of prostate cancer Hum Pathol 23 1992 211
89. P.F. Schellhammer Radical prostatectomy. Patterns of local failure and survival in 67 patients Urology 31 1988 191
90. H.P. Schmid J.E. McNeal An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer Am J Surg Pathol 16 1992 184
91. H.-P. Schmid J.E. McNeal T.A. Stamey Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume Cancer 71 1993 2031
92. D.L. Scrivner J.S. Meyer N. Rujanavech Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies J Urol 146 1991 1034
93. M.S. Shurbaji J.H. Kalbfleisch T.S. Thurmond Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer Hum Pathol 26 1995 106
94. American Cancer Society Cancer Facts and Figures: 1992 1992 American Cancer Society Atlanta
95. P.C. Sogani A. Israel P.H. Lieberman Gleason grading of prostate cancer: A predictor of survival Urology 25 1985 223
96. T.A. Stamey D.D. Dietrick M.M. Issa Large, organ confined, impalpable transition zone prostate cancer: Association with metastatic levels of prostate specific antigen J Urol 149 1993 510
97. T.A. Stamey F.S. Freiha J.E. McNeal Localized prostate cancer: Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 1993 933
98. T.A. Stamey J.N. Kabalin J.E. McNeal Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J Urol 141 1989 1076
99. A. Stein J.B. DeKernion R.B. Smith Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer J Urol 147 1992 942
100. T.J. Stormont G.M. Farrow R.P. Myers Clinical stage BO or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration Urology 41 1993 3
101. I.M. Thompson E.J. Zeidman Extended follow-up of stage A1 carcinoma of the prostate Urology 33 1989 455
102. N. Tinari C. Natoli D. Angelucci DNA and S-phase fraction analysis by flow cytometry in prostate cancer Cancer 71 1993 1289
103. B. Tribukait F. Schroder A. Bocking Clinical utility of cellular DNA measurements in prostate carcinoma Scand J Urol Nephrol 162 suppl 1994 51
104. G. Vallancien G. Bochereau O. Wetzel Influence of preoperative positive seminal vesicle biopsy on the staging of prostate cancer J Urol 152 1994 1152
105. D. van den Ouden B. Tribukait J.H.M. Blom Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: Impact on time to progression J Urol 150 1993 400
106. A. Villers J.E. McNeal E.A. Redwine The role of perineural space invasion in local spread of prostatic adenocarcinoma J Urol 142 1989 763
107. P.C. Walsh H. Lepor The role of radical prostatectomy in the management of prostatic cancer Cancer 60 1987 526
108. M. Watanabe T. Ushijima H. Kakiuchi p53 gene mutations in human prostate cancer in Japan: Different mutation spectra between Japan and western countries Jpn J Cancer Res 85 1994 904
109. V.E. Weldon F.R. Tavel H. Neuwirth Failure of focal prostate cancer on biopsy to predict focal prostate cancer: The importance of prevalence J Urol 154 1995 1074
110. V.E. Weldon F.R. Tavel H. Neuwirth Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy J Urol 153 1995 1565
111. G.K. Zagars A.C. von Eschenbach A.G. Ayala Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy Cancer 72 1993 1709
112. G. Zhang N.F. Wasserman A.A. Sidi Long-term followup results after expectant management of stage A1 prostatic cancer J Urol 146 1991 99